JP7154384B2 - 乳牛の乾乳における経口ボーラスの使用 - Google Patents
乳牛の乾乳における経口ボーラスの使用 Download PDFInfo
- Publication number
- JP7154384B2 JP7154384B2 JP2021508079A JP2021508079A JP7154384B2 JP 7154384 B2 JP7154384 B2 JP 7154384B2 JP 2021508079 A JP2021508079 A JP 2021508079A JP 2021508079 A JP2021508079 A JP 2021508079A JP 7154384 B2 JP7154384 B2 JP 7154384B2
- Authority
- JP
- Japan
- Prior art keywords
- bolus
- oral
- cows
- acid
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18173742.0 | 2018-05-23 | ||
| EP18173742 | 2018-05-23 | ||
| PCT/EP2019/062958 WO2019224149A1 (en) | 2018-05-23 | 2019-05-20 | Use of an oral bolus in the drying-off of dairy cattle |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021520417A JP2021520417A (ja) | 2021-08-19 |
| JP2021520417A5 JP2021520417A5 (https=) | 2022-01-12 |
| JP7154384B2 true JP7154384B2 (ja) | 2022-10-17 |
Family
ID=62235859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021508079A Active JP7154384B2 (ja) | 2018-05-23 | 2019-05-20 | 乳牛の乾乳における経口ボーラスの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10966921B2 (https=) |
| EP (1) | EP3668525A1 (https=) |
| JP (1) | JP7154384B2 (https=) |
| KR (1) | KR20210013202A (https=) |
| CN (1) | CN112153972A (https=) |
| AU (1) | AU2019272711B2 (https=) |
| BR (1) | BR112020023845A2 (https=) |
| CA (1) | CA3091955A1 (https=) |
| CL (1) | CL2020002843A1 (https=) |
| EA (1) | EA202092782A1 (https=) |
| MX (1) | MX2020012468A (https=) |
| UA (1) | UA129834C2 (https=) |
| WO (1) | WO2019224149A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
| AR122366A1 (es) * | 2020-01-27 | 2022-09-07 | Ceva Sante Animale | Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche |
| UY39022A (es) * | 2020-01-27 | 2021-07-30 | Ceva Sante Animale | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria |
| HUE067496T2 (hu) | 2020-12-08 | 2024-10-28 | Ruminant Biotech Corp Ltd | Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5360823A (en) | 1993-11-02 | 1994-11-01 | Dawe's Inc. | Anionic salt formulation for milk fever |
| US5686125A (en) * | 1995-10-31 | 1997-11-11 | Kalmbach Feeds, Inc. | Granular anionic dry cow product |
| EP0943246A1 (en) | 1998-02-04 | 1999-09-22 | Suomen Rehu Oy | Complete fodder |
| US20020150633A1 (en) | 1999-03-31 | 2002-10-17 | Myron Danzer | Dry dairy cow supplement |
| US6521249B2 (en) * | 2001-03-22 | 2003-02-18 | Church & Dwight Co., Inc. | Feedstock for prepartum dairy cattle |
| US9497981B2 (en) | 2012-06-28 | 2016-11-22 | Phibro Animal Health Corporation | Medicated particulate animal feed supplements and methods of preparation |
| CN105029016B (zh) * | 2015-07-10 | 2019-03-15 | 石河子大学 | 围产前期奶牛专用糊化阴离子盐添加剂及其制备方法 |
| AU2018212566B2 (en) * | 2017-01-24 | 2022-11-24 | OmniGen Research, L.L.C. | Granulated feed supplement and methods for making and using |
| EP3764807A4 (en) * | 2018-03-14 | 2021-11-03 | Sustainable Community Development, LLC | PROBIOTIC AND FOOD ADDITIVE COMPOSITION |
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
| EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
| US11723919B2 (en) | 2020-06-12 | 2023-08-15 | Phibro Animal Health Corporation | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D |
-
2019
- 2019-05-20 WO PCT/EP2019/062958 patent/WO2019224149A1/en not_active Ceased
- 2019-05-20 UA UAA202008093A patent/UA129834C2/uk unknown
- 2019-05-20 KR KR1020207037286A patent/KR20210013202A/ko active Pending
- 2019-05-20 EP EP19724508.7A patent/EP3668525A1/en active Pending
- 2019-05-20 AU AU2019272711A patent/AU2019272711B2/en active Active
- 2019-05-20 CA CA3091955A patent/CA3091955A1/en active Pending
- 2019-05-20 BR BR112020023845-7A patent/BR112020023845A2/pt unknown
- 2019-05-20 JP JP2021508079A patent/JP7154384B2/ja active Active
- 2019-05-20 EA EA202092782A patent/EA202092782A1/ru unknown
- 2019-05-20 MX MX2020012468A patent/MX2020012468A/es unknown
- 2019-05-20 CN CN201980034405.8A patent/CN112153972A/zh active Pending
- 2019-05-20 US US16/416,428 patent/US10966921B2/en active Active
-
2020
- 2020-11-03 CL CL2020002843A patent/CL2020002843A1/es unknown
-
2021
- 2021-03-02 US US17/189,317 patent/US11890374B2/en active Active
Non-Patent Citations (2)
| Title |
|---|
| J. Dairy Sci.,2009年,Vol.92,No.7,p3194-3203 |
| SANDRA, R Stokes,Anionic Salt Programs for Close-Up Dry Cows[online],1998年,p.1-4,[検索日2021年9月22日],インターネット<URL:https://oaktrust.library.tamu.edu/bitstream/handle/1969.1/86766/pdf_1016.pdf?sequence=1> |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020012468A (es) | 2021-02-09 |
| JP2021520417A (ja) | 2021-08-19 |
| US20190358154A1 (en) | 2019-11-28 |
| US20210177747A1 (en) | 2021-06-17 |
| US11890374B2 (en) | 2024-02-06 |
| KR20210013202A (ko) | 2021-02-03 |
| CA3091955A1 (en) | 2019-11-28 |
| CL2020002843A1 (es) | 2021-04-23 |
| EP3668525A1 (en) | 2020-06-24 |
| BR112020023845A2 (pt) | 2021-04-13 |
| AU2019272711A1 (en) | 2020-11-19 |
| EA202092782A1 (ru) | 2021-04-19 |
| WO2019224149A1 (en) | 2019-11-28 |
| AU2019272711B2 (en) | 2024-10-03 |
| US10966921B2 (en) | 2021-04-06 |
| CN112153972A (zh) | 2020-12-29 |
| UA129834C2 (uk) | 2025-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Goff | Calcium and magnesium disorders | |
| JP7154384B2 (ja) | 乳牛の乾乳における経口ボーラスの使用 | |
| Goff | Macromineral disorders of the transition cow | |
| Goff | The monitoring, prevention, and treatment of milk fever and subclinical hypocalcemia in dairy cows | |
| Desjardins-Morrissette et al. | The effect of tube versus bottle feeding colostrum on immunoglobulin G absorption, abomasal emptying, and plasma hormone concentrations in newborn calves | |
| JP7441946B2 (ja) | 非ヒト動物の乾乳におけるsglt-2阻害剤の使用 | |
| Wu et al. | Calcium homeostasis, acid–base balance, and health status in periparturient Holstein cows fed diets with low cation–anion difference | |
| Fürll et al. | Effect of multiple intravenous injections of butaphosphan and cyanocobalamin on the metabolism of periparturient dairy cows | |
| Beggs et al. | Implications of prolonged milking time on time budgets and lying behavior of cows in large pasture-based dairy herds | |
| Collier et al. | Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows | |
| Maynou et al. | Effects of oral administration of acidogenic boluses at dry-off on performance and behavior of dairy cattle | |
| Bachmann et al. | Effects of a sustained release formulation of 1, 25-dihydroxyvitamin D3-glycosides for milk fever prevention on serum 1, 25-dihydroxyvitamin D3, calcium and phosphorus in dairy cows | |
| Stevenson et al. | The effects of calcium supplementation of dairy cattle after calving on milk, milk fat and protein production, and fertility | |
| Shen et al. | Transfer efficiency of melamine from feed to milk in lactating dairy cows fed with different doses of melamine | |
| Geyer et al. | Cobalt deficiency in cattle in the north eastern region of Wisconsin | |
| Leslie et al. | Assessment of selenium supplementation by systemic injection at birth on pre-weaning calf health | |
| EA046153B1 (ru) | Применение перорального болюса при запуске молочного рогатого скота | |
| BR122024001079A2 (pt) | Uso de um bolus oral e métodos relacionados | |
| Smith et al. | Comparison of plasma methionine response to 3 rumen-protected methionine products in lactating Holstein dairy cows | |
| Couto Serrenho | Field study of the effect of an anionic supplement on the incidence of hypocalcemia, clinical disease, production, and reproduction in early lactation in dairy herds | |
| Goff | Transition period management and nutrition problems-A few solutions | |
| Moita et al. | Effects of a potentiated zinc oxide on growth performance, incidence of diarrhea, mineral excretion, and bone breaking strength of nursery pigs | |
| Wickramasinghe et al. | Effects of L-glutamine supplementation on growth, starter intake and health of early-weaned dairy Heifer calves | |
| BR122023024692A2 (pt) | Uso de inibidores de sglt-2 na secagem de mamíferos não humanos | |
| Block | Dietary cation-anion balance: a review of definitions and responses in prepartum and lactating cows. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201028 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211004 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211227 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20211227 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220525 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220818 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220905 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221004 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7154384 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |